Clinical trials demonstrate substantial weight reduction with these medications: semaglutide typically produces approximately 15% weight loss in non-diabetic patients, while tirzepatide has shown up to 22% weight loss in clinical trials
Pharmacology Biochemistry and Behavior, 13 , 53-61
Cases of medullary thyroid carcinoma (MTC) have been reported with other drugs in the same class, but a direct causal relationship in humans has not been established
In clinical trials, patients treated with semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic had more weight loss compared to those treated with a placebo
In addition, overall mean body weight of all participants was 91.5 kg and, as such, it is uncertain whether our findings are applicable to individuals with type 2 diabetes who are not overweight or obese
Kidney Function and Safety The kidneys help remove waste and extra fluids from the body